TSND-201, a rapid-acting treatment for PTSD and other Central Nervous System (CNS) disorders (T89)

Summary of poster presentation: Preclinical evidence for TSND-201’s efficacy in behaviors associated with PTSD, depression and anxiety. Parallel clinical results from IMPACT-1 Part A demonstrate TSND-201’s rapid, robust, and long-lasting effects on PTSD, depression and anxiety symptoms. Results support development of TSND-201 to treat multiple CNS disorders. View Poster

The release as fetched from its publisher. transcendtherapeutics.com ↗